CHA Bundang Medical Center

What CHA Bundang Medical Center does

CHA Bundang Medical Center (차의과학대학교 분당차병원, also doing business as 분당차병원 / CBMC) is a private tertiary general hospital located at 59 Yatap-ro, Bundang-gu, Seongnam, South Korea. Founded in 2000 as part of CHA Medical Group, it operates two main facilities — the general CHA Bundang Medical Center and CHA Bundang Women's Medical Center — alongside more than 15 specialty centers covering cancer, robotic surgery, fertility (CHA University Fertility Center Bundang, described as the largest in Asia), neurology, cardiovascular care, endoscopy, prostate, organ transplantation, spine/pain, joint disease, diabetes, oriental medicine, and health promotion. It holds Korea's first da Vinci SP single-port robotic surgery system (adopted 2017), Novalis TX, PET/CT, SPECT/CT, C-RAD, RapidArc, brachytherapy, confocal laser endomicroscopy, and intraoperative CT with neuro-navigation. The hospital also runs dedicated research infrastructure including a Human Research Protection Center (HRPC, FERCAP-certified), a Clinical Trial Center, a Global Stem Cell Clinical Trials Center, a Biobank (인체유래물은행), and a Clinical Genomics Center, and has received three consecutive Ministry of Health & Welfare Research-Driven Hospital designations.

The institution serves domestic Korean patients and international patients, with a dedicated International Healthcare Services channel offering multilingual support. Patient acquisition combines phone reservations (1577-4488), online booking, walk-in emergency services, and global referrals via the CHA Medical Group network spanning 7 countries and 86 medical institutions (including Hollywood Presbyterian Medical Center, City Fertility Australia, and Singapore Medical Group). Revenue is generated through standard Korean National Health Insurance-reimbursed services across outpatient, inpatient, emergency, surgical, and diagnostic lines, supplemented by premium non-insured services such as VIP rooms (up to ₩1,190,000/day), robotic surgery, IVF, and oncology specialties — a hybrid regulated-plus-premium model. The hospital has delivered measurable clinical outcomes including 15,000+ gynecologic robotic surgery cases (leading in Korea), 1,500 breast cancer surgeries, 1,000 urology da Vinci cases, less than 3% one-year restenosis post-coronary stent, and Grade 1 cancer treatment quality ratings sustained for 5–7 consecutive years across breast, colorectal, stomach, and lung cancers.

Name

CHA Bundang Medical Center

Legal name

차의과학대학교 분당차병원

Website

https://bundang.chamc.co.kr

Company type

Private

Founded year

2000

Operating status

Operating

Ownership category

akta.pro rank

Product category

Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (62211), General Medical and Surgical Hospitals (622110)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industry

Chronic Care & Complex Care Management (HSABAIAD)

Keywords

• General hospital services
• Cancer treatment center
• Fertility treatment services
• Robotic surgery
• Women's healthcare

Headquarters

HQ city

Seongnam

HQ country

South Korea

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Services Revenue: Comprehensive hospital services including outpatient consultations, inpatient care, emergency services, surgical procedures, diagnostic imaging, laboratory tests, and specialized cancer treatments. Revenue generated from consultation fees, procedure charges, hospital room accommodations, medication dispensing, and medical examinations.
2. Specialized Treatment Services: Premium revenue streams from robotic surgeries, fertility treatments (IVF), cancer treatments, and other specialized medical procedures. Includes both non-surgical treatments and advanced surgical interventions.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Core offering

CHA Bundang Medical Center is a tertiary general hospital providing inpatient and outpatient medical care, emergency services, specialized cancer treatment, robotic and minimally invasive surgery, fertility/reproductive medicine, and preventive health screenings. It also operates CHA Bundang Women's Medical Center, the Fertility Center (Asia's largest), the Advanced Cancer Research Center, and the CHAUM premium anti-aging wellness brand, supported by 17 specialty centers and advanced medical equipment.

Product overview

CHA Bundang Medical Center operates as a comprehensive medical center network consisting of two main hospital facilities: CHA Bundang Medical Center (general hospital) and CHA Bundang Women's Medical Center (specialized women's hospital), along with the CHA Bundang Women's Medical Center's associated Fertility Center (난임센터). The center provides specialized medical services through dedicated centers including the Advanced Cancer Research Center, Robotic Surgery Center (da Vinci SP), Neurological Center, Cardiovascular Center, Endoscopy Center, Prostate Center, Organ Transplantation Center, Spine/Pain Center, Joint Disease Center, Diabetes Center, Oriental Medicine Center, and Health Promotion Center. The medical center also operates extensive clinical research infrastructure including the Human Research Protection Center (HRPC), Clinical Trial Center, and Global Stem Cell Clinical Trials Center. Advanced medical equipment includes da Vinci robotic surgery systems, Novalis TX radiotherapy, PET/CT and SPECT/CT imaging, C-RAD systems, brachytherapy, RapidArc, and confocal laser endomicroscopy. The CHAUM sub-brand provides premium anti-aging and wellness services. The center is part of the larger CHA Medical Group network spanning 7 countries with 86 medical institutions.

Differentiator

Problem solved

Functional benefit

Brands

• CHAUM (차움): Future-oriented medical institution and premium anti-aging life center
• HI-Pass

Products and services

• CHA Bundang Medical Center (General Hospital) Main general hospital facility providing comprehensive inpatient, outpatient, emergency, and specialty medical services across multiple disciplines including cancer, neurology, cardiology, and surgery.
• CHA Bundang Women's Medical Center Specialized women's hospital offering obstetrics, gynecology, fertility treatments, postpartum care, and female urology services.
• Advanced Cancer Research Center (첨단연구암센터) Comprehensive cancer treatment facility with multidisciplinary team approach offering chemotherapy, radiotherapy, oncothermia, photodynamic therapy (PDT), hyperthermia, and stem cell/immune cell therapy.
• Robotic Surgery Center Robotic surgical center using the da Vinci SP system to perform minimally invasive laparoscopic procedures across general surgery, thoracic surgery, urology, gynecology, and otolaryngology.
• Fertility Center (CHA University Fertility Center Bundang) The largest fertility center in Asia offering IVF, ICSI, preimplantation genetic diagnosis (PGD), and personalized therapies including PRP and immunotherapy with a multidisciplinary approach.
• Neurological Center (Brain Health Center) Brain and nervous system treatment center offering brain tumor surgery, stroke care, Parkinson's disease treatment, and neurosurgical procedures using intraoperative CT, automatic neuro-navigation, and Diffusion Tensor Imaging (DTI).
• Cardiovascular Center Heart and vascular disease treatment center providing percutaneous coronary intervention, stent insertion, heart valve surgery, arrhythmia treatments including TAVI, and cardiac rehabilitation.
• Endoscopy Center Advanced endoscopic diagnosis and treatment center offering gastrointestinal endoscopy, pancreaticobiliary endoscopy, endoscopic submucosal dissection (ESD), POEM procedures, and confocal laser endomicroscopy.
• Prostate Center Specialized prostate care center offering brachytherapy, robotic surgery, and treatments for prostate cancer, hypertrophy, and prostatitis.
• Organ Transplantation Center Organ transplant facility performing kidney, liver, corneal, bone marrow, and stem cell transplantation with reported 100% success rates.
• Spine Center / Pain Center Integrated spine and pain management center providing surgical and non-surgical treatments for spinal diseases, deformity surgery, and pain management.
• Joint Disease & Reconstruction Center Joint treatment center specializing in hip and knee replacement arthroplasty, arthroscopy, sports injuries, and biological treatments using stem cells.
• Diabetes Center Comprehensive diabetes and thyroid disease care center offering one-stop multidisciplinary consultation, specialized clinics, and patient education programs.
• Oriental Medicine Center Integrated Western-Oriental medicine center offering acupuncture, herbal medicine, and interdisciplinary treatments combining conventional and traditional Korean/Chinese medicine approaches.
• Health Promotion Center Preventive healthcare facility providing customized health screening (check-up) programs and lifelong health management services.
• Gynecologic Cancer Center Specialized gynecologic cancer treatment center for cervical, endometrial, ovarian, and peritoneal cancers with robotic surgery and fertility-preserving treatment protocols.
• Newborn Intensive Care Center (NICU) Ministry-designated largest newborn intensive care unit in Gyeonggi Province providing comprehensive care for high-risk infants with 24/7 specialist coverage.
• Human Research Protection Center (HRPC) Clinical research support facility providing IRB administration, quality assurance, education, and compliance management for research protocols; holds FERCAP international certification.
• Clinical Trial Center Clinical research facility managing Phase 0-3 clinical trials and investigator-initiated studies with comprehensive trial management services.
• Global Stem Cell Clinical Trials Center International stem cell therapy research center conducting clinical trials for advanced cell-based treatments.
• CHAUM (Comprehensive Anti-aging Life Centers) Premium anti-aging and wellness sub-brand of CHA Medical Group offering integrated health management combining Eastern and Western medical approaches with nutrition, meditation, and spa programs.
• Love Messenger Campaign 27-year social contribution program providing free cardiac and other medical treatments to overseas Koreans and international patients in need.

Quantifiable outcome

• Less than 3% restenosis rate within one year after coronary stent insertion
• +4 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature8 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• CHA Medical Group NetworkcoreStrategic or Co-development PartnerCHA Bundang is part of CHA Medical Group, a major Korean healthcare network with 7 countries and 86 medical institutions including domestic hospitals (Gangnam, Gumi, Ilsan), overseas facilities (Hollywood Presbyterian Medical Center), fertility centers, CHA University, and CHA Bio Group companies.
• Hollywood Presbyterian Medical Center (LA, USA)coreStrategic or Co-development PartnerOverseas affiliate providing international patient referrals and collaborative healthcare services across the CHA network spanning North America and Asia.
• CHA Bio Group (차바이오텍, 차케어스, 차바이오에프앤씨 등)coreTechnology or IntegrationBiopharmaceutical and healthcare subsidiaries including CHA Biotech, CHA Cares, CHA Bio F&C, Seoul CRO, CMG Pharmaceutical, CHA-Meditech, CHA Healthcare, and stem cell banks (iCord, Bio Insurance). Integrated research and commercial development partnership.
• CHA University (차의과학대학교)coreStrategic or Co-development PartnerAcademic affiliation providing medical education, research collaboration, and continuous medical training programs. CHA Bundang serves as teaching hospital for medical students and residents.
• City Fertility (Australia)minorStrategic or Co-development PartnerInternational fertility network partnership providing cross-border reproductive health services and expertise sharing.
• Singapore Medical GroupminorStrategic or Co-development PartnerSoutheast Asia healthcare collaboration for medical tourism and patient referrals within the CHA international network.
• Ajou University HospitalminorStrategic or Co-development PartnerJoint clinical research collaboration on stem cell therapy for acute cerebral infarction and development of suicide gene-transferred stem cell treatment for glioblastoma.

Scale indicators15 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Bumrungrad International Hospital: Asia's leading medical tourism hospital in Bangkok. Comparable in premium international patient services and complex specialty care, but operates in a different geography and regulatory environment.

Direct peers

• Hanyang University Medical Center: Seoul-based academic hospital with comprehensive specialty centers including cancer and robotic surgery. Comparable as a tertiary academic competitor, though smaller than the top-tier Seoul hospitals.
• Seoul National University Hospital: Premier Korean academic medical center with full-spectrum tertiary care, advanced cancer treatment, and research-driven hospital designation. Directly competes for complex oncology, fertility, and neurosurgery cases nationally.
• Korea University Anam Hospital: Major Korean academic medical center offering tertiary care, oncology, and robotic surgery. Directly comparable in scope and competes for the same Seoul/Gyeonggi patient catchment.
• CHA Gangnam Medical Center: Sister hospital within CHA Medical Group, also offering comprehensive specialty care including CHA fertility services. Comparable as a group-affiliated facility and a key internal peer for resource allocation and patient referrals.
• Samsung Medical Center: One of Korea's largest tertiary academic hospitals, headquartered in Seoul. Directly comparable to CHA Bundang as a comprehensive cancer, robotic surgery, and specialty provider competing for the same patient pool, but with a stronger Seoul brand and larger scale.
• Severance Hospital (Yonsei University): Yonsei-affiliated academic hospital in Seoul with comparable cancer, robotic surgery, and women's health programs. Targets similar high-acuity patient segments with strong international patient services.
• Asan Medical Center: Korea's largest hospital by patient volume, operated by the Asan Foundation in Seoul. Comparable across oncology, organ transplant, robotic surgery, and specialty centers, with deeper research funding and a stronger Seoul catchment area.

Others

• Hollywood Presbyterian Medical Center: CHA Medical Group's US affiliate in Los Angeles. Comparable as part of the same group network, providing international patient referrals and cross-border care coordination rather than direct competition.

Emerging players

• Maria Fertility Hospital: Korean specialty fertility hospital network. Directly competes with CHA Bundang's IVF center in the domestic fertility segment but focuses exclusively on reproductive medicine rather than full-service tertiary care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCQnbEcKjCBh-lEdX18Jimgg
• Facebookfacebook.com/CHAMCBD
• Instagraminstagram.com/bundang_cha
• LinkedInlinkedin.com/company/cha-health-systems

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CHA Bundang Medical Center